Sangamo Therapeutics Company
Sangamo Therapeutics is a genomic medicine company conducting research & development across four distinct but complementary technology platforms – gene therapy, cell therapy, in vivo genome editing, and in vivo genome regulation.
Estimated Revenue:
$10M to $50M
Funding Status:
IPO
Industry:
Genomic and Epigenominc Instabillity
Technology:
Others
Founded Date:
01.01.1995
Headquarters:
United States
Total Funding:
$74 M
Employee Number:
251-500